Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
179.28
116.88
120.24
149.24
108.62
59.29
44.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
179.28
116.88
120.24
149.24
108.62
59.29
44.51
Raw Material Cost
18.65
7.11
1.75
1.66
0.90
0.91
0.88
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.92
6.87
3.71
4.86
1.35
0.34
0.00
Selling and Distribution Expenses
113.06
105.74
113.01
91.31
76.60
74.59
69.41
Other Expenses
1.55
1.77
5.66
6.04
5.87
5.25
4.69
Total Expenditure (Excl Depreciation)
155.09
137.37
175.03
158.21
137.59
128.38
117.19
Operating Profit (PBDIT) excl Other Income
24.2
-20.5
-54.800000000000004
-9
-29
-69.1
-72.69999999999999
Other Income
2.09
2.27
0.68
0.05
0.58
2.53
2.20
Operating Profit (PBDIT)
28.51
-16.98
-52.55
-7.77
-27.68
-65.88
-69.89
Interest
7.92
6.87
3.71
4.86
1.35
0.34
0.00
Exceptional Items
0.00
0.00
-1.32
-3.52
0.00
0.00
0.00
Gross Profit (PBDT)
160.63
109.77
118.49
147.57
107.73
58.38
43.63
Depreciation
2.23
1.24
1.00
1.16
0.71
0.68
0.59
Profit Before Tax
18.37
-25.09
-58.57
-17.31
-29.74
-66.89
-70.48
Tax
0.88
0.00
0.00
0.60
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.48
-25.09
-58.57
-17.91
-29.74
-66.89
-70.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.48
-25.09
-58.57
-17.91
-29.74
-66.89
-70.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.48
-25.09
-58.57
-17.91
-29.74
-66.89
-70.48
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
3.29
-28.64
-13.62
30.37
34.03
53.81
109.88
Earnings per share (EPS)
0.99
-1.44
-3.4
-1.05
-1.76
-4.0
-4.39
Diluted Earnings per share
0.99
-1.44
-3.4
-1.05
-1.76
-4.0
-4.39
Operating Profit Margin (Excl OI)
13.49%
-17.53%
-45.1%
-6.01%
-26.67%
-116.53%
-163.3%
Gross Profit Margin
11.49%
-20.41%
-47.88%
-10.82%
-26.73%
-111.68%
-157.02%
PAT Margin
9.75%
-21.47%
-48.71%
-12.0%
-27.38%
-112.83%
-158.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 53.38% vs -2.75% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 169.72% vs 57.17% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 236.79% vs 63.72% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 14.49% vs 86.49% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Rigel Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
179.28
0.00
179.28
Other Operating Income
0.00
0.00
0.00
Total Operating income
179.28
0.00
179.28
Raw Material Cost
18.65
1.62
17.03
1,051.23%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.92
1.53
6.39
417.65%
Selling and Distribution Expenses
113.06
3.60
109.46
3,040.56%
Other Expenses
1.55
2.13
-0.58
-27.23%
Total Expenditure (Excl Depreciation)
155.09
28.03
127.06
453.30%
Operating Profit (PBDIT) excl Other Income
24.19
-28.03
52.22
186.30%
Other Income
2.09
0.57
1.52
266.67%
Operating Profit (PBDIT)
28.51
-25.83
54.34
210.38%
Interest
7.92
1.53
6.39
417.65%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
160.63
-1.62
162.25
10,015.43%
Depreciation
2.23
1.62
0.61
37.65%
Profit Before Tax
18.37
-28.98
47.35
163.39%
Tax
0.88
0.04
0.84
2,100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
17.48
-29.02
46.50
160.23%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17.48
-29.02
46.50
160.23%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.48
-29.02
46.50
160.23%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
3.29
7.68
-4.39
-57.16%
Earnings per share (EPS)
0.99
-4.91
5.90
120.16%
Diluted Earnings per share
0.99
-4.91
5.90
120.16%
Operating Profit Margin (Excl OI)
13.49%
0.00%
0.00
13.49%
Gross Profit Margin
11.49%
0.00%
0.00
11.49%
PAT Margin
9.75%
0.00%
0.00
9.75%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 17.93 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 53.38% vs -2.75% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 1.75 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 169.72% vs 57.17% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.64 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 236.79% vs 63.72% in Dec 2023
Annual - Interest
Interest 0.79 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 14.49% vs 86.49% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.49%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
